Daihan Pharmaceutical Co.,Ltd.

A023910

KR7023910003

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-06 pm EDT			5-day change	1st Jan Change
28,550 ^KRW	+0.18%		+0.53%	+2.88%

2023	Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index	CI
2023	Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) added to S&P Global BMI Index

September 19, 2016 at 12:00 am EDT

Latest news about Daihan Pharmaceutical Co.,Ltd.

Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index	23-09-18	CI
Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Tranche Update on Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 28, 2022.	23-01-02	CI
Tranche Update on Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 28, 2022.	23-01-02	CI
Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback announced on September 28, 2022, has closed with 120,000 shares, representing 2% for KRW 3,418.04 million.	22-12-28	CI
Daihan Pharmaceutical Co.,Ltd. announces an Equity Buyback for 120,000 shares.	22-09-28	CI
Daihan Pharmaceutical Co.,Ltd. authorizes a Buyback Plan.	22-09-27	CI
Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) added to S&P Global BMI Index	16-09-19	CI
Hangaram Investment Management Co.,Ltd acquired 5.1% stake in Daihan Pharmaceutical Co.,Ltd..	14-02-10	CI
Daihan Pharmaceutical Co. Ltd. closed an Equity Buyback in the amount of KRW770.46 mm	12-08-17	CI
Daihan Pharmaceutical Co. Ltd. announces an Equity Buyback	12-07-04	CI

Chart Daihan Pharmaceutical Co.,Ltd.

Duration

Period

More charts

DAIHAN PHARMACEUTICAL CO.,LTD. is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company provides infusions, including basic infusions, nutritional infusions and infusions for special uses; injections for anesthetics, vitamin-minerals, autonomic nerve systems, hypnotic-sedatives, antispasmodics, antidotes, hormones, analgesics, respiratory and others; contrast media, such as drugs for computed tomography (CT) uses and magnetic resonance imaging (MRI) uses, and other drugs, such as drugs for irrigations, ointments, inhalants, as well as quasi-drugs such as hand gels, lens clean solutions and others.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Daihan Pharmaceutical Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
DAIHAN PHARMACEUTICAL CO.,LTD.	+2.88%	124M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.32%	43.95B
OTSUKA HOLDINGS CO., LTD.	+22.22%	22.49B
SANDOZ GROUP AG	+11.68%	14.71B
CIPLA LIMITED	+11.31%	13.77B
ZYDUS LIFESCIENCES LIMITED	+42.32%	12.3B
ONO PHARMACEUTICAL CO., LTD.	-8.70%	7.03B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.33%	5.48B

Generic Pharmaceuticals